The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review
Cancer Management and Research · 2026-08 · Volume 18 · 1-16
DOI: 10.2147/cmar.s623567 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Management and Research, 2026-08. Verfasst von Feng Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250014, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
Gynecological cancers mainly include ovarian, cervical, and endometrial cancers. Treatment continues to evolve but still suffers from high mortality rates, significant side effects, and medication resistance, making it challenging to achieve a successful outcome. Several key bioactive constituents in Rhizoma Paridis and Ramulus Cinnamomi show excellent biological activity against cancer cells. They are being developed as anti-gynecological tumor therapeutics.
Purpose
This study aims to comprehensively review the existing data on the effectiveness of Ramulus Cinnamomi, Rhizoma Paridis , and their key active components (such as cinnamaldehyde, cinnamic acid, coumarins, polyphyllin I, polyphyllin II, polyphyllin VI, polyphyllin VII, and polyphyllin E) in treating gynecological tumors, focusing mainly on ovarian, cervical, and endometrial cancers. The research also delves into the mechanisms behind these treatments and evaluates their limitations.
Results
Ramulus cinnamomi and Rhizoma Paridis , along with their primary bioactive components, have been shown to inhibit the growth of ovarian cancer, cervical cancer, and endometrial cancer cells, as well as reduce tumor growth. Additionally, they have been found to enhance the effectiveness of chemotherapy medications and enhance the quality of life for patients through various signaling pathways.
Conclusion
Preclinical research suggests that Rhizoma Paridis and Ramulus cinnamomi may serve as candidate drugs with potential anti-cancer value for the management of gynecological malignancies. Keywords: Rhizoma Paridis , Ramulus Cinnamomi , ovarian cancer, cervical cancer, endometrial cancer
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, 250014, People's Republic of China.
- Laboratory Center, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, 250014, People's Republic of China.
- Department of Gynecology, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, 250014, People's Republic of China.
ORCID-Profile: Feng Li
Zitieren
APA
Li, F., Niu, W., & Shi, W. (2026). The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review. Cancer Management and Research, Volume 18, 1-16. https://doi.org/10.2147/cmar.s623567
Vancouver
Li F, Niu W, Shi W. The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review. Cancer Management and Research. 2026;Volume 18:1-16. doi:10.2147/cmar.s623567
BibTeX
@article{Li2026,
author = {Li, Feng and Niu, Weipin and Shi, Wei},
title = {The Mechanisms of Ramulus Cinnamomi and Rhizoma Paridis in Gynecological Cancers: A Narrative Review},
journal = {Cancer Management and Research},
year = {2026},
volume = {Volume 18},
pages = {1--16},
doi = {10.2147/cmar.s623567}
}
EUVIMED